Status:

COMPLETED

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites

Lead Sponsor:

Baxter Healthcare Corporation

Conditions:

Breast Cancer

Lumpectomy

Eligibility:

FEMALE

19+ years

Phase:

PHASE3

Brief Summary

This study will monitor the safety of FS VH S/D and will evaluate whether FS VH S/D is superior to conventional surgical procedures in the reduction of lymphatic leakage by sealing the axillary lympha...

Eligibility Criteria

Inclusion

  • Written informed consent has been obtained from the subject prior to FS VH S/D administration
  • Female subjects \>= 19 years of age
  • Subjects with breast cancer scheduled to undergo lumpectomy of the breast and level I and II axillary lymphadenectomy with two separate incisions

Exclusion

  • Subjects with known hypersensitivity to aprotinin or other components of the product
  • Subjects with immunodeficiency
  • Subjects with increased red cell production (e.g., in hemolytic anemia)
  • Subjects with coagulation disorders shown by exceeding the normal range of any of following: prothrombin time (PT), Quick, activated partial thromboplastin time (aPTT), fibrinogen level, or thrombocytes.
  • Subjects having previously had axillary surgery
  • Subjects having undergone irradiation therapy to the axillary tissue
  • Subjects having ever received chemotherapy before the surgery

Key Trial Info

Start Date :

June 1 2001

Trial Type :

INTERVENTIONAL

End Date :

December 1 2002

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00161980

Start Date

June 1 2001

End Date

December 1 2002

Last Update

October 23 2006

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

Landeskrankenhaus St. Pölten

Sankt Pölten, Lower Austria, Austria, 3100

2

Allgemeines Krankenhaus der Stadt Wien, University Clinic for Gynecology

Vienna, Austria, 1090

3

Centre Régional de Lutte Contre le Cancer, Centre Eugène Marquis

Rennes, France, 35062

4

Ludwig-Maximilians-Universität

Munich, Germany, 80337

Efficacy and Safety of Fibrin Sealant Vapor Heated Solvent/Detergent Treated (FS VH S/D) for Reduction of Lymphatic Leakage by Sealing Axillary Lymph Node Dissection Sites | DecenTrialz